Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Maximilian P SchmidJacob Christian LindegaardUmesh MahantshettyKari TanderupIna Jürgenliemk-SchulzChristine Haie-MederLars U FokdalAlina SturdzaPeter J HoskinBarbara SegedinKjersti BruheimFleur HuangBhavana RaiRachel CooperElzbieta van der Steen-BanasikErik Van LimbergenBradley R PietersPrimoz PetricDariga RamazanovaRobin RistlSadhana KannanRohini W HawaldarStefan EckerKathrin KirchheinerLi Tee TanRemi NoutNicole NesvacilAstrid de LeeuwRichard PötterChristian Kirisitsnull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
The present study demonstrates the safety and validity of the GYN GEC-ESTRO/ICRU-89 target concept and provides large-scale evidence for dose prescription and new risk factors for LF in MR-IGABT in locally advanced cervical cancer.